In terms of market performance, Teva- Pharmaceutical Industries Ltd. ADR had a fairly even. The highest value for the stock in the past year was $19.31 on 11/06/24, and the lowest value was recorded at $9.35 on 12/11/23.
52-week price history of TEVA Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -8.86% away from its 52-week high, while its distance from the 52-week low is 88.24%. The stock’s price range during the 52-week period has remained between $9.35 and $19.31. In the Healthcare sector, the company’s shares saw a trading volume of around 6.22 million for the day, which was evidently lower than the average daily volume of 6.81 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 0.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.97B and boasts a workforce of 37226 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.64, with a change in price of +1.26. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 7,566,890 in trading volume during the last 100 days, posting a change of +7.71%.
Examining TEVA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 3.18. Similarly, the long-term debt-to-equity ratio is also 2.75.
TEVA Stock Stochastic Average
Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the past 50 days is presently 45.89%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 69.21%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 68.42% and 63.23%, respectively.
TEVA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 68.58% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 4.45%. Over the past 30 days, the price of TEVA has fallen by 0.57%. And in the last five days, it has surged by 5.71%.
